Highnoon Laboratories Limited (HINOON)

PHARMACEUTICALSALLSHRKMIALLSHRKSE100KSE100PR

1020.54

+1.72%

As of 10-Jul-2026

52 Week RangeCurrent: 1020.54

755.561241.00

Updated: 10-Jul-2026

1M+5.8%

3M+7.3%

1Y+3.0%

3Y+201.9%

5Y+178.7%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 09-Jul-2026

P/E

12.78x

P/B

3.76x

P/S

2.04x

EV/Sales

7.29x

EV/EBITDA

25.40x

Showing 37 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	31.02	41.47	45.35	61.41	77.75
DPS	14.37	15.81	30.01	40.01	50.00
BVPS	108.78	140.52	181.14	211.80	248.58
PER	29.40x	21.99x	22.12x	16.34x	12.90x
Div Yield	1.43%	1.58%	2.99%	3.99%	4.98%
PBV	9.22	7.14	5.54	4.74	4.04
EV/Sales	3.90x	3.31x	2.69x	2.13x	1.94x
Price/Sales	4.09x	3.36x	2.74x	2.29x	2.06x
EV/EBITDA	19.19x	14.45x	13.59x	8.76x	7.00x
EV/Gross Profit	7.89x	6.51x	5.64x	4.14x	3.55x

Metric	2021	2022	2023	2024	2025
Gross Margin	49.35%	50.77%	47.64%	51.43%	54.78%
EBITDA Margin	20.30%	22.87%	19.77%	24.30%	27.76%
Operating Margin	18.98%	21.67%	18.51%	22.96%	26.31%
Pretax Margin	18.24%	21.16%	17.00%	20.86%	25.53%
Net Margin	13.91%	15.28%	12.37%	14.03%	15.97%

Metric	2021	2022	2023	2024	2025
ROE	35.28%	36.60%	28.20%	31.26%	33.77%
ROA	24.46%	25.72%	19.48%	21.63%	23.90%
ROTA	33.38%	36.47%	29.15%	35.40%	39.37%
ROCE	38.33%	41.92%	32.24%	43.58%	48.81%